In Brief This Week: Danaher, SeqLL, Yourgene Health, Thermo Fisher Scientific, More - NewsBreak

NEW YORK – Danaher said this week that it has completed its $9.6 billion acquisition of Aldevron, which will operate as a standalone company under Danaher's life sciences segment. Danaher announced the acquisition in June and said on a conference call in July that it expects the company to generate $500 million in revenues in 2022. Fargo, North Dakota-based Aldevron manufactures plasmid DNA, mRNA, and proteins for biotechnology and pharmaceutical customers in research, clinical, and commercial applications.